V
Vifor Pharma AG
F:G2AB
Vifor Pharma AG
F:G2AB
Price:
30.6
EUR
Market Closed
Market Cap:
€9.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Vifor Pharma AG
F:G2AB
|
CH |
|
F
|
Freehold Royalties Ltd
F:1FH
|
CA |
|
Aneka Tambang Tbk PT
OTC:PAEKY
|
ID |
|
Spark Power Group Inc
TSX:SPG
|
CA |
|
A
|
Atos SE
SWB:AXI
|
FR |
|
L
|
Luminar Technologies Inc
F:9FS
|
US |
|
Canadian Solar Inc
NASDAQ:CSIQ
|
CA |
|
Lonking Holdings Ltd
HKEX:3339
|
CN |
|
H
|
Hochschild Mining PLC
SWB:H3M
|
UK |
|
Surya Semesta Internusa Tbk PT
IDX:SSIA
|
ID |
|
S
|
Spark New Zealand Ltd
ASX:SPK
|
NZ |
|
Aneka Tambang Tbk PT
F:AKTA
|
ID |
|
T
|
TG Metals Ltd
ASX:TG6
|
AU |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of G2AB.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
G2AB
Multiples-Based Value
Not Available
